Obstructive uropathy — clinical features, investigation and treatment

Obstructive uropathy is structural or functional obstruction to urine flow anywhere from the renal calyces to the external urethral meatus. When it causes renal parenchymal damage it is termed obstructive nephropathy; dilatation of the collecting system is hydronephrosis.

Geriatric significance: it is one of the most important and potentially reversible causes of renal failure in old age, and is the classic post-renal cause of acute kidney injury alongside stones, tumour and stricture.

The central geriatric trap: prostatic enlargement produces a slow, silent obstruction that gradually reduces kidney function and is often not recognised until it is too late — largely because the patient becomes polyuric rather than oliguric. By the time obstruction is diagnosed the damage may be irreversible, and renal function recovers only partially even after relief.

It also drives infection: the pathogenesis of pyelonephritis in older adults is strongly related to obstructive uropathy, and prostatic hypertrophy with obstruction predisposes older men to urinary tract infection.

Lower tract (commonest in the elderly): benign prostatic hyperplasia, prostate carcinoma, urethral stricture, bladder neck stenosis, bladder calculi, blocked indwelling catheter, phimosis or meatal stenosis, and severe pelvic organ prolapse or cystocele in women.

Upper tract: renal or ureteric calculi, urothelial tumours, extrinsic compression by pelvic or retroperitoneal malignancy (cervical, ovarian, colorectal, lymphoma), retroperitoneal fibrosis, and post-radiotherapy or post-surgical ureteric stricture.

Functional (neurogenic) obstruction: detrusor–sphincter dyssynergia in suprasacral cord lesions and multiple sclerosis; acontractile bladder in diabetic autonomic neuropathy; and drug-induced retention (anticholinergics, opioids, tricyclics, antipsychotics, α-agonists, antihistamines).

Faecal impaction is a common, easily reversible precipitant of outlet obstruction in frail older patients.

Acute lower tract obstruction (acute urinary retention): sudden inability to pass urine, severe suprapubic pain, a palpable tender bladder — and in the older patient it may present atypically as delirium, agitation, a fall or "off legs". Acute retention has a quality-of-life impact comparable to that of myocardial infarction.

Chronic lower tract obstruction: insidious LUTS — hesitancy, weak stream, straining, intermittency, incomplete emptying, terminal dribbling — with overflow (dribbling) incontinence, a painless distended bladder, and nocturnal enuresis. Pain is characteristically absent.

Acute upper tract obstruction: loin pain radiating to the groin (ureteric colic), nausea, vomiting, haematuria, and fever if infected.

Chronic upper tract obstruction: often silent; presents with anaemia, nocturia, polyuria, hypertension or unexplained rising creatinine.

Complications: post-renal AKI and chronic kidney disease; recurrent UTI, pyelonephritis and pyonephrosis with sepsis; bladder stones and diverticula; hyperkalaemia and metabolic acidosis (type 4 renal tubular acidosis); hypertension; and, after relief, post-obstructive diuresis.

Danger combination to recognise instantly: obstruction plus fever plus a raised inflammatory response = infected obstructed system, a urological emergency requiring drainage within hours.

Bedside: abdominal examination for a distended bladder, digital rectal examination, bladder ultrasound for post-void residual, and urinalysis (infection, haematuria).

Laboratory: serum creatinine and urea (mg/dL), electrolytes including potassium (mEq/L), bicarbonate, calcium (mg/dL), haemoglobin (g/dL), and blood glucose (mg/dL); urine culture; PSA (ng/mL) once infection and retention have resolved.

Ultrasound of kidneys, ureters and bladder is the first-line imaging investigation — it detects hydronephrosis, measures residual urine and prostate size, is safe, cheap, radiation-free and requires no contrast. Remember that hydronephrosis may be absent in early obstruction, in dehydration, and in retroperitoneal fibrosis or encasing malignancy.

Non-contrast CT KUB for suspected calculus and for defining the level and cause of upper-tract obstruction.

Further tests as indicated: MR urography where contrast is contraindicated; diuretic renography (MAG-3) to confirm functional obstruction and assess split renal function; antegrade or retrograde pyelography; cystoscopy for stricture, bladder tumour or stone; and urodynamics/pressure-flow study to distinguish true obstruction from detrusor underactivity.

Uroflowmetry as a non-invasive screen — Qmax <10 mL/s on a voided volume >150 mL supports obstruction or impaired contractility.

Principle: relieve the obstruction promptly, treat infection, correct metabolic consequences, then treat the cause.

Acute retention: immediate urethral catheterisation; if this fails or is contraindicated (stricture, recent urethral surgery), suprapubic catheterisation. Record the drained volume. Start an α-blocker before a trial without catheter, which improves the chance of successful voiding.

Upper-tract obstruction: decompress by percutaneous nephrostomy or retrograde ureteric stenting — nephrostomy is generally preferred in sepsis and in a poorly drained infected system.

Infected obstructed kidney (pyonephrosis) is an emergency: resuscitate, take cultures, start broad-spectrum intravenous antibiotics and drain urgently; delay is associated with high mortality.

Correct metabolic derangement: hyperkalaemia, acidosis and uraemia; dialysis if refractory.

Anticipate post-obstructive diuresis after relief of chronic obstruction — monitor urine output hourly, weigh daily, and replace fluid and electrolytes carefully; it is usually physiological but may cause hypovolaemia, hyponatraemia, hypokalaemia and hypomagnesaemia in frail older patients.

Definitive treatment of the cause: medical therapy for BPH (α-blocker ± 5-α-reductase inhibitor) or TURP / laser enucleation; stone removal by ureteroscopy or lithotripsy; urethral dilatation or urethroplasty for stricture; oncological treatment or long-term stenting for malignant compression; steroids and ureterolysis for retroperitoneal fibrosis; clean intermittent self-catheterisation for a neurogenic acontractile bladder; and disimpaction plus a bowel regimen where faecal loading is contributory.

Review and stop precipitating drugs — anticholinergics, opioids, tricyclics, antipsychotics and α-agonists.

Prognosis: recovery of renal function depends on the duration and completeness of obstruction and on the pre-existing renal reserve; partial recovery is the rule after prolonged obstruction, so early detection is the only effective strategy. Follow up renal function and residual volume after relief.

Geriatric caveat: in a frail patient with advanced malignancy, decompression may prolong a poor-quality life — the decision to stent or drain should follow comprehensive geriatric assessment and a discussion of goals of care.

KDIGO AKI guidance and current practice emphasise urgent exclusion of a post-renal cause in every episode of AKI, with bedside bladder scan and renal ultrasound as immediate steps — the most rapidly reversible AKI aetiology in older adults.

Point-of-care ultrasound (POCUS) performed by physicians has become routine on acute geriatric and emergency units since 2023, shortening the time to detection of retention and hydronephrosis; a bladder scan is now expected before labelling an older patient's AKI as pre-renal.

Minimally invasive surgical therapies for BPH — water vapour thermal therapy, prostatic urethral lift, and prostatic artery embolisation (added to the AUA guideline in the 2023 amendment) — allow definitive relief of prostatic obstruction in frail men unfit for anaesthesia, replacing indefinite long-term catheterisation in selected patients.

Laser enucleation (HoLEP/ThuLEP) is now preferred over open prostatectomy for very large glands, with lower morbidity, shorter catheter time and size-independent efficacy.

Nephrostomy versus stent in malignant obstruction: contemporary evidence supports individualised choice with early palliative-care input, since survival after decompression for advanced pelvic malignancy is often short — an important shared-decision point in geriatric oncology.

Indian context: obstructive uropathy from BPH, stone disease and cervical or prostate malignancy remains a leading reversible cause of CKD in Indian older adults; TURP, ureteric stenting and nephrostomy are covered under AB-PMJAY, with the Ayushman Vay Vandana Card providing universal cover for those aged 70 and above.

Obstructive uropathy is the most readily reversible cause of renal failure in the elderly.

Chronic prostatic obstruction presents with polyuria, not oliguria — hence late diagnosis.

Acute retention in an older person may present as delirium or a fall.

Ultrasound KUB is the first-line investigation; absent hydronephrosis does not exclude obstruction.

Infected obstructed kidney = emergency drainage plus intravenous antibiotics.

Anticipate post-obstructive diuresis after relieving chronic obstruction.

Recovery of renal function is only partial after prolonged obstruction.